Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 101

1.

NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020.

Thompson JA, Schneider BJ, Brahmer J, Andrews S, Armand P, Bhatia S, Budde LE, Costa L, Davies M, Dunnington D, Ernstoff MS, Frigault M, Kaffenberger BH, Lunning M, McGettigan S, McPherson J, Mohindra NA, Naidoo J, Olszanski AJ, Oluwole O, Patel SP, Pennell N, Reddy S, Ryder M, Santomasso B, Shofer S, Sosman JA, Wang Y, Weight RM, Johnson-Chilla A, Zuccarino-Catania G, Engh A.

J Natl Compr Canc Netw. 2020 Mar;18(3):230-241. doi: 10.6004/jnccn.2020.0012.

PMID:
32135517
2.

Gut Microbiome and Immune Checkpoint Inhibitor-Induced Enterocolitis.

Abu-Sbeih H, Wang Y.

Dig Dis Sci. 2020 Mar;65(3):797-799. doi: 10.1007/s10620-020-06103-x. Review.

PMID:
32040664
3.

An Aggressive Approach Toward a Case of Refractory Ulcerative Colitis With Uncertain Etiology in the Context of Chronic Myeloid Leukemia.

Peng Y, Thomas AS, Wei D, Tan D, Wang Y.

Inflamm Bowel Dis. 2020 Mar 4;26(4):e26-e27. doi: 10.1093/ibd/izaa016. No abstract available.

PMID:
32016290
4.

Cap-fitted endoscopic mucosal resection of ≥ 20 mm colon flat lesions followed by argon plasma coagulation results in a low adenoma recurrence rate.

Raju GS, Lum P, Abu-Sbeih H, Ross WA, Thirumurthi S, Miller E, Lynch P, Lee J, Bhutani MS, Shafi M, Weston B, Rashid A, Wang Y, Chang GJ, Carlson R 3rd, Hagan K, Davila M, Stroehlein J.

Endosc Int Open. 2020 Feb;8(2):E115-E121. doi: 10.1055/a-1012-1811. Epub 2020 Jan 22.

5.

Clinical characteristics of colitis induced by taxane-based chemotherapy.

Chen E, Abu-Sbeih H, Thirumurthi S, Mallepally N, Khurana S, Wei D, Altan M, Morris VK, Tan D, Barcenas CH, Wang Y.

Ann Gastroenterol. 2020 Jan-Feb;33(1):59-67. doi: 10.20524/aog.2019.0431. Epub 2019 Nov 21.

6.

Correction to: Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis.

Abu-Sbeih H, Herrera LN, Tang T, Altan M, Chaftari AM, Okhuysen PC, Jenq RR, Wang Y.

J Immunother Cancer. 2019 Dec 17;7(1):352. doi: 10.1186/s40425-019-0832-5.

7.

Neutropenic Enterocolitis: Clinical Features and Outcomes.

Abu-Sbeih H, Ali FS, Chen E, Mallepally N, Luo W, Lu Y, Foo WC, Qiao W, Okhuysen PC, Adachi JA, Hachem RY, Altan M, Jenq RR, Wang Y.

Dis Colon Rectum. 2020 Mar;63(3):381-388. doi: 10.1097/DCR.0000000000001548.

PMID:
31842164
8.

Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel Disease.

Abu-Sbeih H, Faleck DM, Ricciuti B, Mendelsohn RB, Naqash AR, Cohen JV, Sellers MC, Balaji A, Ben-Betzalel G, Hajir I, Zhang J, Awad MM, Leonardi GC, Johnson DB, Pinato DJ, Owen DH, Weiss SA, Lamberti G, Lythgoe MP, Manuzzi L, Arnold C, Qiao W, Naidoo J, Markel G, Powell N, Yeung SJ, Sharon E, Dougan M, Wang Y.

J Clin Oncol. 2020 Feb 20;38(6):576-583. doi: 10.1200/JCO.19.01674. Epub 2019 Dec 4.

PMID:
31800340
9.

Ecological Security Assessment Based on Ecological Footprint Approach in Hulunbeir Grassland, China.

Guo S, Wang Y.

Int J Environ Res Public Health. 2019 Nov 29;16(23). pii: E4805. doi: 10.3390/ijerph16234805.

10.

Immune-checkpoint inhibitors induced diarrhea and colitis: a review of incidence, pathogenesis and management.

Abu-Sbeih H, Ali FS, Wang Y.

Curr Opin Gastroenterol. 2020 Jan;36(1):25-32. doi: 10.1097/MOG.0000000000000593.

PMID:
31609734
11.

Reply to J. Delyon et al.

Abu-Sbeih H, Ali FS, Owen DH, Ricciuti B, Naqash AR, Wang Y.

J Clin Oncol. 2019 Dec 20;37(36):3564-3565. doi: 10.1200/JCO.19.02133. Epub 2019 Oct 9. No abstract available.

PMID:
31596634
12.

Management Considerations for Immune Checkpoint Inhibitor-Induced Enterocolitis Based on Management of Inflammatory Bowel Disease.

Abu-Sbeih H, Wang Y.

Inflamm Bowel Dis. 2019 Sep 27. pii: izz212. doi: 10.1093/ibd/izz212. [Epub ahead of print]

PMID:
31560045
13.

Discovery of a series of selective and cell permeable beta-secretase (BACE1) inhibitors by fragment linking with the assistance of STD-NMR.

Fang WS, Sun DY, Yang S, Cheng C, Moschke K, Li T, Sun S, Lichtenthaler SF, Huang J, Wang Y.

Bioorg Chem. 2019 Nov;92:103253. doi: 10.1016/j.bioorg.2019.103253. Epub 2019 Sep 13.

PMID:
31557620
14.

Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis.

Abu-Sbeih H, Herrera LN, Tang T, Altan M, Chaftari AP, Okhuysen PC, Jenq RR, Wang Y.

J Immunother Cancer. 2019 Sep 5;7(1):242. doi: 10.1186/s40425-019-0714-x. Erratum in: J Immunother Cancer. 2019 Dec 17;7(1):352.

15.

Gastrointestinal Adverse Events Observed After Chimeric Antigen Receptor T-Cell Therapy.

Abu-Sbeih H, Tang T, Ali FS, Luo W, Neelapu SS, Westin JR, Okhuysen PC, Foo WC, Curry JL, Richards DM, Ge PS, Wang Y.

Am J Clin Oncol. 2019 Oct;42(10):789-796. doi: 10.1097/COC.0000000000000596.

PMID:
31478934
16.

Galectin-3 may serve as a marker for poor prognosis in colorectal cancer: A meta-analysis.

Wang C, Zhou X, Ma L, Zhuang Y, Wei Y, Zhang L, Jin S, Liang W, Shen X, Li C, Wang Y, Pang L.

Pathol Res Pract. 2019 Oct;215(10):152612. doi: 10.1016/j.prp.2019.152612. Epub 2019 Aug 20. Review.

PMID:
31474314
17.

Ambient volatile organic compounds in a suburban site between Beijing and Tianjin: Concentration levels, source apportionment and health risk assessment.

Yang Y, Ji D, Sun J, Wang Y, Yao D, Zhao S, Yu X, Zeng L, Zhang R, Zhang H, Wang Y, Wang Y.

Sci Total Environ. 2019 Dec 10;695:133889. doi: 10.1016/j.scitotenv.2019.133889. Epub 2019 Aug 12.

PMID:
31426000
18.

The synthesis and biological evaluation of chondroitin sulfate E glycodendrimers.

Yang S, Zhang H, Liu Q, Sun S, Lei P, Zhao Z, Wu L, Wang Y.

Future Med Chem. 2019 Jun;11(12):1403-1415. doi: 10.4155/fmc-2019-0011. Epub 2019 Jul 15. Erratum in: Future Med Chem. 2020 Jan;12(2):172.

PMID:
31304829
19.

Patients with breast cancer may be at higher risk of colorectal neoplasia.

Abu-Sbeih H, Ali FS, Ge PS, Barcenas CH, Lum P, Qiao W, Bresalier RS, Bhutani MS, Raju GS, Wang Y.

Ann Gastroenterol. 2019 Jul-Aug;32(4):400-406. doi: 10.20524/aog.2019.0387. Epub 2019 May 20.

20.

Evolution of boundary layer ozone in Shijiazhuang, a suburban site on the North China Plain.

Zhao W, Tang G, Yu H, Yang Y, Wang Y, Wang L, An J, Gao W, Hu B, Cheng M, An X, Li X, Wang Y.

J Environ Sci (China). 2019 Sep;83:152-160. doi: 10.1016/j.jes.2019.02.016. Epub 2019 Feb 27.

PMID:
31221378

Supplemental Content

Loading ...
Support Center